Skip to main content
Contact Us
Subscribe
E-Edition
63°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about CLDX
Recent news which mentions CLDX
< Previous
1
2
Next >
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
June 21, 2022
Tickers
ABBV
ACER
ARDX
CLDX
Tags
ACER
EXEL
CLDX
From
Benzinga
Stocks That Hit 52-Week Lows On Thursday
June 02, 2022
Tickers
ACOR
ADN
AERI
AFIB
Tags
News
NPCE
LXEH
From
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
June 01, 2022
Tickers
ACB
AERI
ALBO
AMTI
Tags
INZY
BARK
REVB
From
Benzinga
77 Biggest Movers From Yesterday
June 01, 2022
Tickers
ACOR
AMR
ANF
ANGN
Tags
CTT
Top Gainers
ICVX
From
Benzinga
7 Micro-Cap Stocks to Buy and Hold for the Next 10 Years
May 11, 2022
Tickers
AMEH
CDMO
CLDX
CSTL
Tags
IWC
CSTL
Market News
From
InvestorPlace
Celldex Therapeutics: Q4 Earnings Insights
February 28, 2022
Tickers
CLDX
Tags
Market News
Benzinga
Earnings
From
Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
Tickers
AAON
ACAD
ACHC
AGM
Tags
SUPN
SAIL
TGNA
From
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 15, 2021
Tickers
ADTX
AVDL
CKPT
CLDX
Tags
SNOA
CLDX
Top Gainers
From
Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
Tickers
ADTX
AFIB
AGTC
ARAV
Tags
BSGM
CLDX
BDTX
From
Benzinga
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
Tickers
ABBV
ADXN
AGTC
AKYA
Tags
AZYO
FBIO
PASG
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 17, 2021
September 17, 2021
Tickers
ACCD
ADC
ALV
ARMK
Tags
TRQ
CREE
RKLB
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 10, 2021
September 10, 2021
Tickers
ACHC
AEM
AGL
ALHC
Tags
SFT
FRPT
LVOX
From
Benzinga
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
Tickers
ABSI
ADGI
APLS
AXNX
Tags
Offerings
ZNTL
MDT
From
Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
Tickers
ABSI
ABT
AZN
BIVI
Tags
TMO
IMRX
TRVI
From
Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
Tickers
ADIL
ADMA
AFMD
ALEC
Tags
ADMA
CERE
LYEL
From
Benzinga
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
Tickers
ABT
ACRS
ADGI
APOP
Tags
MDT
GMAB
SRDX
From
Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
Tickers
ABBV
ADGI
ASMB
AXNX
Tags
FDA
MRNA
MEIP
From
Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
Tickers
ACIU
ADGI
ALKS
ALPMY
Tags
SRDX
BLFS
PDSB
From
Benzinga
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
August 31, 2021
Tickers
ABSI
AGEN
ALKS
AXNX
Tags
DRMA
ZNTL
GLPG
From
Benzinga
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
Tickers
AGEN
ALKS
ALZN
BLFS
Tags
BYSI
REGN
TCRX
From
Benzinga
The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO
August 26, 2021
Tickers
ABBV
ALZN
AMRX
ANVS
Tags
MRK
INMB
Penny Stocks
From
Benzinga
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug
August 25, 2021
Tickers
AGEN
ALRN
AMRX
ARGX
Tags
SWAV
EGRX
SAVA
From
Benzinga
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
August 24, 2021
Tickers
ABBV
AGEN
ALKS
AVTE
Tags
MDXG
RGEN
NUVL
From
Benzinga
Stocks That Hit 52-Week Highs On Monday
August 23, 2021
Tickers
ABBV
ACN
ADBE
ADSK
Tags
ULTA
NSP
DKS
From
Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
August 06, 2021
Tickers
ACAD
ACXP
ADGI
AKRO
Tags
INVA
BXRX
VECT
From
Benzinga
How Good Were Celldex Therapeutics' Latest Clinical Results?
July 24, 2021
Tickers
CLDX
Tags
CLDX
Market News
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For July 22, 2021
July 22, 2021
Tickers
ABNB
ALIZY
ASAN
ASO
Tags
CARR
TCBI
Upgrades
From
Benzinga
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
July 15, 2021
Tickers
ABCL
ACET
ACHL
ADVM
Tags
GLPG
IKT
Offerings
From
Benzinga
The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues
July 14, 2021
Tickers
ABCL
ACET
ACHL
ALLO
Tags
MIRO
News
LPTX
From
Benzinga
Celldex Therapeutics Raises $250M Via Equity To Support Development Of Skin Disease Candidate
July 14, 2021
Tickers
CLDX
Tags
Market News
Skin Disorder
Biotech
From
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.